When was BioPharma Services founded?

BioPharma Services was founded in 2006.

Where is BioPharma Services located?

BioPharma Services is headquartered in Toronto, Canada. It is registered at Creve Coeur, Missouri.

Who is the current CEO of BioPharma Services?

Renzo DiCarlo of BioPharma Services.

How many employees does BioPharma Services have?

As of Sep 30, 2026, the latest employee count at BioPharma Services is 292.

Where does BioPharma Services rank among its competitors?

BioPharma Services ranks 3rd amongst 100 active competitors, of which 7 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was MindBio Therapeutics, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of BioPharma Services?

BioPharma Services' top competitors include Celerion, Altasciences and MindBio Therapeutics. Among them, MindBio Therapeutics secured the most recent funding round in April, 2026.

BioPharma Services - 2026 Company Profile, Team & Competitors

BioPharma Services is an acquired company based in Toronto (Canada), founded in 2006. It operates as a Provider of early stage clinical trial services. The company has 100 active competitors, including 7 funded and 23 that have exited. Its top competitors include companies like Celerion, Altasciences and MindBio Therapeutics.

Company Details

BioPharma offers bioequivalence (BE) studies and phase I/IIa clinical trials for pharmaceutical, biotech, and medical device companies. The company's service offerings include clinical trial research (phase I/IIa), bioequivalence studies, pharmacokinetic analysis, regulatory affairs, data management, quality assurance, project management, and statistical services.

Website: biopharmaservices.com
Social
Email ID: *****@biopharmaservices.com
Phone Number: +1 **********
Registered Address: Creve Coeur, Missouri

Key Metrics

Founded Year

2006

Location

Toronto, Canada

Stage

Acquired

Ranked

3^rd among 100 active competitors

Employee Count

292 as on Sep 30, 2026

Similar Companies

Celerion & 120 more

Exit Details

Acquired by Think Research (Jul 16, 2021)

View BioPharma Services' full profile

BioPharma Services is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOPHARMA SERVICES USA CIN: 464229670 , United States, Active	Dec 31, 1999	-	5 (As on Dec 31, 2023)	-

BioPharma Services got acquired by Think Research on Jul 16, 2021 at an acquisition amount of $*****.

Click here to take a look at BioPharma Services's acquisition in detail

BioPharma Services has not raised any funding rounds yet.

BioPharma Services' employee count trend

BioPharma Services has 292 employees as of Sep 26. Here is BioPharma Services's employee count trend over the years:

Employee count trend for BioPharma Services

Uncover BioPharma Services' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioPharma Services include Celerion, Altasciences and MindBio Therapeutics. Here is the list of Top 10 competitors of BioPharma Services, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Celerion 2010, Lincoln (United States), Acquired	Translational medicine experts accelerating drug development for global patient impact	-	H.I.G. Private Equity, H.I.G. Capital & 7 others	51/100
2nd	Altasciences 2015, Laval (Canada), Acquired	Early phase CRO	-	Apollo Investment Corporation, Signet Healthcare Partners ... & 1 others	50/100
3rd	BioPharma Services 2006, Toronto (Canada), Acquired	Provider of early stage clinical trial services	-	-	48/100
4th	MindBio Therapeutics 2021, Melbourne (Australia), Public	Provider of phase I & II clinical trial services for mental health diseases	-	Blackhawk Growth Corp, Hardenbrook Group	44/100
5th	Avance Clinical 2018, Thebarton (Australia), Late Stage	Provider of clinical development services	-	Riverside, Genesis Capital	43/100
6th	Aditum Bio 2019, Cambridge (United States), Unfunded	CRO focused on clinical trial on phase II studies	-	-	42/100
7th	iCardiac Technologies 2006, Rochester (United States), Acquired	Company offering core laboratory services mainly for cardiac safety testing and respiratory diseases	$4M	Stonehenge Growth Equity Partners, Norwest ... & 4 others	41/100
8th	Unravel Biosciences 2020, Boston (United States), Seed	CRO offering early stage clinical development of drugs	$500K	BoxOne Ventures, Beresford Ventures	41/100
9th	Ventura Biomed 2021, Germany, Unfunded	CRO offering early stage drug development services	-	-	40/100
10th	Biomind Labs 2005, Toronto (Canada), Public	Developer of novel pharmaceuticals targeting neurological disorders and related conditions	-	-	39/100